Cargando…
Proteome‐minimized outer membrane vesicles from Escherichia coli as a generalized vaccine platform
Because of their potent adjuvanticity, ease of manipulation and simplicity of production Gram‐negative Outer Membrane Vesicles OMVs have the potential to become a highly effective vaccine platform. However, some optimization is required, including the reduction of the number of endogenous proteins,...
Autores principales: | Zanella, Ilaria, König, Enrico, Tomasi, Michele, Gagliardi, Assunta, Frattini, Luca, Fantappiè, Laura, Irene, Carmela, Zerbini, Francesca, Caproni, Elena, Isaac, Samine J., Grigolato, Martina, Corbellari, Riccardo, Valensin, Silvia, Ferlenghi, Ilaria, Giusti, Fabiola, Bini, Luca, Ashhab, Yaqoub, Grandi, Alberto, Grandi, Guido |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886703/ https://www.ncbi.nlm.nih.gov/pubmed/33643549 http://dx.doi.org/10.1002/jev2.12066 |
Ejemplares similares
-
Synergistic Protective Activity of Tumor-Specific Epitopes Engineered in Bacterial Outer Membrane Vesicles
por: Grandi, Alberto, et al.
Publicado: (2017) -
Bacterial outer membrane vesicles engineered with lipidated antigens as a platform for Staphylococcus aureus vaccine
por: Irene, Carmela, et al.
Publicado: (2019) -
Vaccination With a FAT1-Derived B Cell Epitope Combined With Tumor-Specific B and T Cell Epitopes Elicits Additive Protection in Cancer Mouse Models
por: Grandi, Alberto, et al.
Publicado: (2018) -
Multi-Antigen Outer Membrane Vesicle Engineering to Develop Polyvalent Vaccines: The Staphylococcus aureus Case
por: König, Enrico, et al.
Publicado: (2021) -
Anti-Tumor Efficacy of In Situ Vaccination Using Bacterial Outer Membrane Vesicles
por: Caproni, Elena, et al.
Publicado: (2023)